CAS 18742-02-4: 2-(2-Bromoethyl)-1,3-dioxolane

2-(2-Bromoethyl)-1,3-dioxolane is a synthetic chemical compound that is used for the asymmetric synthesis of fatty acids. It can be prepared by the cross-coupling reaction of ethyl formate with bromoethane and copper(II) acetate in trifluoroacetic acid. The reaction produces an unsymmetrical product with two aldehyde groups and two halides on each side of the molecule. It can also be prepared by the reaction of 2-bromoethanol with sodium formaldehyde sulfoxylate and sodium methoxide in methanol. This process produces a symmetrical molecule with one aldehyde group on each side of the molecule. 2-(2-Bromoethyl)-1,3-dioxolane has been shown to have anti-cancer properties in carcinoma cell lines.

This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

2-(2-Bromoethyl)-1,3-dioxolane is used as a pharmaceutical intermediate, dioxolanes, acetals, ketals, building blocks, chemical synthesis, organic building blocks and oxygen compounds. 1,1-(Ethylenedioxy)-3-bromopropane is used in the synthesis of EGFR inhibitors. Also used in the synthesis of orally active agents of cancer and cell proliferation with quinoline substructures. It is also used as flavouring agent. This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications 1,1-(Ethylenedioxy)-3-bromopropane is used in the synthesis of EGFR inhibitors. Also used in the synthesis of orally active agents of cancer and cell proliferation with quinoline substructures. References Zhang, X. et al.: Arch. Pharm., 346, 44 (2013); Lee, Y. et al.: J. Med. Chem., 55, 10363 (2012);

2-(2-Bromoethyl)-1,3-dioxolane